Sources | Names Used |
---|---|
CTRPv2 | doxorubicin:navitoclax (2:1 mol/mol) |
PharmacoGx | doxorubicin:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | MMS22L | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
mRNA | EFCAB7 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
mRNA | KIAA0408 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
mRNA | HIST1H2BN | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
mRNA | ASCL5 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
mRNA | ZNF473 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | MYT1 | CTRPv2 | pan-cancer | AAC | 0.14 | 5e-05 |
mRNA | AGO4 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
mRNA | GCH1 | CTRPv2 | pan-cancer | AAC | 0.13 | 5e-05 |
mRNA | SDC4 | CTRPv2 | pan-cancer | AAC | -0.16 | 5e-05 |